Literature DB >> 19544450

ES cell cycle progression and differentiation require the action of the histone methyltransferase Dot1L.

Evan R Barry1, Winfried Krueger, Caroline M Jakuba, Eric Veilleux, Dominic J Ambrosi, Craig E Nelson, Theodore P Rasmussen.   

Abstract

Mouse embryonic stem cells (ESCs) proliferate with rapid cell cycle kinetics but without loss of pluripotency. The histone methyltransferase Dot1L is responsible for methylation of histone H3 at lysine 79 (H3K79me). We investigated whether ESCs require Dot1L for proper stem cell behavior. ESCs deficient in Dot1L tolerate a nearly complete loss of H3K79 methylation without a substantial impact on proliferation or morphology. However, shortly after differentiation is induced, Dot1L-deficient cells cease proliferating and arrest in G2/M-phase of the cell cycle, with increased levels of aneuploidy. In addition, many aberrant mitotic spindles occur in Dot1L-deficient cells. Surprisingly, these mitotic and cell cycle defects fail to trigger apoptosis, indicating that mouse ESCs lack stringent cell cycle checkpoint control during initial stages of differentiation. Transcriptome analysis indicates that Dot1L deficiency causes the misregulation of a select set of genes, including many with known roles in cell cycle control and cellular proliferation as well as markers of endoderm differentiation. The data indicate a requirement for Dot1L function for early stages of ESC differentiation where Dot1L is necessary for faithful execution of mitosis and proper transcription of many genes throughout the genome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544450      PMCID: PMC6338332          DOI: 10.1002/stem.86

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  39 in total

1.  Allele-specific H3K79 Di- versus trimethylation distinguishes opposite parental alleles at imprinted regions.

Authors:  Purnima Singh; Li Han; Guillermo E Rivas; Dong-Hoon Lee; Thomas B Nicholson; Garrett P Larson; Taiping Chen; Piroska E Szabó
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

2.  DOT1L-controlled cell-fate determination and transcription elongation are independent of H3K79 methylation.

Authors:  Kaixiang Cao; Michal Ugarenko; Patrick A Ozark; Juan Wang; Stacy A Marshall; Emily J Rendleman; Kaiwei Liang; Lu Wang; Lihua Zou; Edwin R Smith; Feng Yue; Ali Shilatifard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-19       Impact factor: 11.205

3.  A novel disrupter of telomere silencing 1-like (DOT1L) interaction is required for signal transducer and activator of transcription 1 (STAT1)-activated gene expression.

Authors:  Shaili Shah; Melissa A Henriksen
Journal:  J Biol Chem       Date:  2011-10-15       Impact factor: 5.157

4.  DOT1L regulates dystrophin expression and is critical for cardiac function.

Authors:  Anh T Nguyen; Bin Xiao; Ronald L Neppl; Eric M Kallin; Juan Li; Taiping Chen; Da-Zhi Wang; Xiao Xiao; Yi Zhang
Journal:  Genes Dev       Date:  2011-02-01       Impact factor: 11.361

Review 5.  The emerging roles of DOT1L in leukemia and normal development.

Authors:  C M McLean; I D Karemaker; F van Leeuwen
Journal:  Leukemia       Date:  2014-05-23       Impact factor: 11.528

Review 6.  The diverse functions of Dot1 and H3K79 methylation.

Authors:  Anh Tram Nguyen; Yi Zhang
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

7.  Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases.

Authors:  Timothy P Wakeman; Qinhong Wang; Junjie Feng; Xiao-Fan Wang
Journal:  EMBO J       Date:  2012-02-28       Impact factor: 11.598

8.  Characterization of the DOT1L network: implications of diverse roles for DOT1L.

Authors:  Geunyeong Park; Zihua Gong; Junjie Chen; Ja-Eun Kim
Journal:  Protein J       Date:  2010-04       Impact factor: 2.371

Review 9.  Concise review: Leukemia stem cells in personalized medicine.

Authors:  Monica L Guzman; John N Allan
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

10.  CREB trans-activation of disruptor of telomeric silencing-1 mediates forskolin inhibition of CTGF transcription in mesangial cells.

Authors:  Zhiyuan Yu; Qun Kong; Bruce C Kone
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.